GLYCEMIC OUTCOMES AND SAFETY WITH MINIMED 780G SYSTEM IN CHILDREN WITH TYPE 1 DIABETES AGED 2-6 YEARS

被引:0
|
作者
Tuomaala, A. -K. [1 ]
Varimo, T. [1 ]
Hakonen, E. [1 ]
Kiiveri, S. [1 ]
Janer, J. [1 ]
Hyvonen, M. [1 ]
Wehkalampi, K. [1 ]
Laakkonen, H. [1 ]
Laakso, S. [1 ]
Harsunen, M. [1 ]
Hero, M. [1 ]
Miettinen, P. [1 ]
Pulkkinen, M. -A. [1 ]
机构
[1] Helsinki Univ Hosp, HUS, Pediat & Adolescence, Helsinki, Finland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
EP005 / #1
引用
收藏
页码:A82 / A82
页数:1
相关论文
共 50 条
  • [21] MiniMed™ 780G Advanced Hybrid Closed-Loop System Study in Pregnant Women with Type 1 Diabetes
    Guibert, Clara
    Amoura, Lamia
    Rakotoarisoa, Luc
    Plat, Francoise
    Sonnet, Emmanuel
    Lablanche, Sandrine
    Treglia, Clemence
    Sarde, Elisa
    Leca, Viviane
    Rimareix, Frederique
    Melki, Vincent
    Baucher, Franciane
    Betari, Bouchra
    Meyer, Laurent
    Kessler, Laurence
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (12) : 893 - 901
  • [22] Implementation of an advanced hybrid closed-loop system (MiniMed 780G) in children and adolescents with type 1 diabetes, in a national diabetes training center
    Gomez, Susana
    Forero, Catalina
    Duran, Paola
    Cespedes, Camila
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 2): : 77 - 77
  • [23] Safety, Metabolic and Psychological Outcomes of Medtronic MiniMed 780G™ in Children, Adolescents and Young Adults: A Systematic Review
    Passanisi S.
    Lombardo F.
    Mameli C.
    Bombaci B.
    Macedoni M.
    Zuccotti G.
    Dovc K.
    Battelino T.
    Salzano G.
    Delvecchio M.
    Diabetes Therapy, 2024, 15 (2) : 343 - 365
  • [24] The LENNY randomised crossover trial demonstrates the Mini-Med 780G system is safe and effective for children aged 2-6
    Battelino, T.
    Kuusela, S.
    Tuomaala, A.
    Shetty, A.
    Campbell, F.
    Rabbone, I.
    Cherubini, V.
    Re, R.
    Gulotta, F.
    di Piazza, F.
    Shin, J.
    Cohen, O.
    DIABETOLOGIA, 2024, 67 : S526 - S526
  • [25] IMPROVED GLYCEMIC OUTCOMES WITH INCREASING AUTOMATION: A REAL-WORLD ANALYSIS OF PATIENTS TRANSITIONING FROM EARLIER MINIMED™ SYSTEMS TO THE MINIMED™ 780G SYSTEM
    Grassi, B.
    Gomez, A. M.
    Calliari, L. E.
    Denise, F.
    Raggio, M.
    Castro, M.
    Mcvean, J.
    Van Den Heuvel, T.
    Castaneda, J.
    Arrieta, A.
    Cohen, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A117 - A118
  • [26] EP018/#412 GLYCEMIC OUTCOMES IN PEDIATRIC AND ADULT INDIVDUALS WITH TYPE 1 DIABETES (T1D) DURING MINIMED™ 780G SYSTEM USE WITH THE GUARDIAN™ 4 SENSOR
    Shin, J.
    Bode, B.
    Brazg, R.
    Buckingham, B.
    Carlson, A.
    Kaiserman, K.
    Kipnes, M.
    Liljenquist, D.
    Philis-Tsimikas, A.
    Pihoker, C.
    Pop-Busui, R.
    Reed, J. C.
    Sherr, J.
    Shulman, D.
    Slover, R.
    Thrasher, J.
    Chen, X.
    Cordero, T.
    Rhinehart, A.
    Vella, M.
    Vigersky, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A87 - A88
  • [27] Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system
    Zhou, Yongwen
    Boucsein, Alisa
    Michaels, Venus R.
    Gray, Madeleine K.
    Jefferies, Craig
    Wiltshire, Esko
    Paul, Ryan G.
    Parry-Strong, Amber
    Pasha, Maheen
    Petrovski, Goran
    de Bock, Martin I.
    Wheeler, Benjamin J.
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 2138 - 2146
  • [28] SYSTEM MINIMED 780G PROVIDES SATISFACTORY GLUCOSE CONTROL IN ADOLESCENTS WITH TYPE 1 DIABETES DURING FOOTBALL SPORTS CAMP
    Gawrecki, A.
    Chrzanowski, J.
    Michalak, A.
    Fendler, W.
    Szadkowska, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A91 - A92
  • [29] Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)
    Goran Petrovski
    Fawziya Al Khalaf
    Judith Campbell
    Emma Day
    Douha Almajaly
    Khalid Hussain
    Maheen Pasha
    Fareeda Umer
    Manar Hamdan
    Amel Khalifa
    BMC Endocrine Disorders, 22
  • [30] Safety and Performance of the Omnipod Hybrid Closed-Loop System in Young Children Aged 2-6 Years with Type 1 Diabetes
    Buckingham, Bruce A.
    Forlenza, Gregory P.
    Sherr, Jennifer
    Galderisi, Alfonso
    Ekhlaspour, Laya
    Lee, Joon Bok
    Oconnor, Jason B.
    Dumais, Bonnie
    Huyett, Lauren M.
    Layne, Jennifer E.
    Ly, Trang T.
    DIABETES, 2019, 68